SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Hamps Bio Limited
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Hamps Bio Limited was originally incorporated under the name "Hamps Bio Private Limited" at ROC, Gujarat, Dadra and Nagar Haveli on January 02, 2007. Subsequently, the Company status changed to Public Limited and the name of the Company was changed to "Hamps Bio Limited". The fresh Certificate of Incorporation was issued on July 12, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in the ethical marketing and distribution of pharma formulation products across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as manufacturing of freeze dried and frozen products in the FMCG industry such as fruits, vegetables, herbs and flowers. The Company is recognized in pharma industry under the brand name "Hamps" and in freeze-dried and frozen food division through own brand "FzyEzy". The Company sell products through more than 50 distributor`s network as on March 31, 2024 and E-commerce platform, including Amazon.com, Amazon.ca, Amazon.eu, Flipkart, Jio Mart, Etc. It sell pharma products primarily in 8 States and Union territories and FDFP products primarily in 4 countries and 22 States and Union territories. In year 2007, the Company commenced operating as an ethical pharmaceutical marketing firm, with the network of its distributors in Gujarat region for distribution of pharmaceutical formulation products across therapeutic area`s as well as consumer health care product. Further, it procure products with various contract manufacturers who has WHO GMP approved manufacturing plant facility. In 2017, the Company started new business segment of Freeze dried and frozen products in FMCG industry. Company issued and allotted 12,20,000 equity shares of Rs 10 each and raised Rs 6.22 crores by way of its IPO in December 2024. The commercial production at the new freeze drying factory at Bhatpore, Surat became operational from April 2025. The Company commissioned a 350 kVA groundmounted solar power plant for the Ankleshwar unit during the year 2025.
Hamps Bio Limited share price as on 05 Dec 2025 is Rs. 24.01. Over the past 6 months, the Hamps Bio Limited share price has increased by 1.05% and in the last one year, it has decreased by 52.8%. The 52-week low for Hamps Bio Limited share price was Rs. 17.11 and 52-week high was Rs. 53.6.
544312
INE0QBD01018
Aug
Hamps Bio Limited FAQs
You can buy Hamps Bio Limited shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Hamps Bio Limited Share.
Company share prices and volatile and keep changing according to the market conditions. As of Dec 05, 2025 12:16 PM the closing price of Hamps Bio Limited was Rs.24.01.
The latest PE ratio of Hamps Bio Limited as of Dec 05, 2025 12:16 PM is 72.06
The latest PB ratio of Hamps Bio Limited as of Dec 05, 2025 12:16 PM is 2.43
The 52-week high of Hamps Bio Limited share price is Rs. 53.60 while the 52-week low is Rs. 17.11
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Dec 05, 2025 12:16 PM, the market cap of Hamps Bio Limited stood at Rs. 20.92 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.